| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Caldwell J, Sever PS |
The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... |
Clin.Pharmacol.Ther. |
1974 |
| Pieri L, Pieri M, Haefely... |
LSD as an agonist dopamine receptors in the striatum |
Nature |
1974 |
| Kelly PH |
Action of LSD on supersensitive mesolimic dopamine receptors |
British J.Pharmac. |
1975 |
| Gershon MD, Robinson RG, ... |
Serotonin Accumulation in the Guinea-Pig Myenteric Plexus: Ion Depende... |
J.Pharmacol.Exp.Ther... |
1976 |
| Masoud AN |
Systematic Identification of Drugs of Abuse II: TLC |
J.Pharm.Sci. |
1976 |
| Da Prada M, Pieri L, Kell... |
Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... |
Ann.N.Y.Acad.Sci. |
1978 |
| Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Battaglia G, Yeh SY, O'He... |
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... |
J Pharmacol Exp Ther |
1987 |
| Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
| Mokler DJ, Robinson SE, R... |
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... |
Eur J Pharmacol |
1987 |
| Peroutka SJ, Pascoe N, Fa... |
Monoamine metabolites in the cerebralspinal fluid of recreational user... |
Research Comm in Sub... |
1987 |
| Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
| Battaglia G, Yeh SY, de S... |
MDMA-induced neurotoxicity: parameters of degeneration and recovery of... |
Pharmacol Biochem Be... |
1988 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
| Johnson M, Letter AA, Mer... |
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... |
J Pharmacol Exp Ther |
1988 |
| Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
| O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
| Ricaurte GA, DeLanney LE,... |
5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergi... |
Brain Res |
1988 |
| Schmidt CJ, Taylor VL |
Direct central effects of acute methylenedioxymethamphetamine on serot... |
Eur J Pharmacol |
1988 |
| Stone DM, Johnson M, Hans... |
Role of endogenous dopamine in the central serotonergic deficits induc... |
J Pharmacol Exp Ther |
1988 |
| Wilkerson G, London ED |
Effects of methylenedioxymethamphetamine on local cerebral glucose uti... |
Neuropharmacology |
1989 |
| Gold LH, Hubner CB, Koob ... |
A role for the mesolimbic dopamine system in the psychostimulant actio... |
Psychopharmacology (... |
1989 |
| Insel TR, Battaglia G, Jo... |
3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... |
J Pharmacol Exp Ther |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Kelland MD, Freeman AS, C... |
(+/-)-3,4-Methylenedioxymethamphetamine-induced changes in the basal a... |
Eur J Pharmacol |
1989 |
| Li AA, Marek GJ, Vosmer G... |
Long-term central 5-HT depletions resulting from repeated administrati... |
Pharmacol Biochem Be... |
1989 |
| Nader MA, Hoffmann SM, Ba... |
Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... |
Psychopharmacology (... |
1989 |
| Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
| Seiden LS, Kleven MS |
Methamphetamine and related drugs: toxicity and resulting behavioral c... |
NIDA Res Monogr |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Whitaker-Azmitia PM, Aron... |
'Ecstasy' (MDMA)-induced panic |
Am J Psychiatry |
1989 |
| Azmitia EC, Murphy RB, Wh... |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for ... |
Brain Res |
1990 |
| Cody JT |
Detection of D,L-amphetamine, D,L-methamphetamine, and illicit ampheta... |
J Anal Toxicol |
1990 |
| Cody JT |
Cross-reactivity of amphetamine analogues with Roche Abuscreen radioim... |
J Anal Toxicol |
1990 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| Gibb JW, Johnson M, Hanso... |
Neurochemical basis of neurotoxicity |
Neurotoxicology |
1990 |
| Hashimoto K, Goromaru T |
Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake ... |
Fundam Clin Pharmaco... |
1990 |
| Hiramatsu M, Cho AK |
Enantiomeric differences in the effects of 3,4-methylenedioxymethamphe... |
Neuropharmacology |
1990 |
| Johnson MP, Huang XM, Obe... |
Behavioral, biochemical and neurotoxicological actions of the alpha-et... |
Eur J Pharmacol |
1990 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| Nash JF |
Ketanserin pretreatment attenuates MDMA-induced dopamine release in th... |
Life Sci |
1990 |
| Schmidt CJ, Taylor VL |
Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by ... |
Eur J Pharmacol |
1990 |
| Paris JM, Cunningham KA |
Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... |
NIDA Res Monogr |
1991 |
| Battaglia G, Sharkey J, K... |
Neuroanatomic specificity and time course of alterations in rat brain ... |
Synapse |
1991 |
| Champney TH, Matthews RT |
Pineal serotonin is resistant to depletion by serotonergic neurotoxins... |
J Pineal Res |
1991 |
| Dornan WA, Katz JL, Ricau... |
The effects of repeated administration of MDMA on the expression of se... |
Pharmacol Biochem Be... |
1991 |
| Fukuto JM, Kumagai Y, Cho... |
Determination of the mechanism of demethylenation of (methylenedioxy)p... |
J Med Chem |
1991 |
| Johnson M, Bush LG, Gibb ... |
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... |
Eur J Pharmacol |
1991 |
| Kumagai Y, Lin LY, Schmit... |
Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl co... |
Chem Res Toxicol |
1991 |
| Pan HS, Wang RY |
The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... |
Brain Res |
1991 |
| Pan HS, Wang RY |
MDMA: further evidence that its action in the medial prefrontal cortex... |
Brain Res |
1991 |
| Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
| Fukuto JM, Kumagai Y, Cho... |
Determination of the mechanism of demethylenation of (methylenedioxy)p... |
J Med Chem |
1991 |
| Hanson GR, Bunker CF, Joh... |
Response of monoaminergic and neuropeptide systems to 4-methylaminorex... |
Eur J Pharmacol |
1992 |
| Berger UV, Gu XF, Azmitia... |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, metham... |
Eur J Pharmacol |
1992 |
| Callaway CW, Geyer MA |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus ... |
Eur J Pharmacol |
1992 |
| Callaway CW, Rempel N, Pe... |
Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced b... |
Neuropsychopharmacol... |
1992 |
| Elayan I, Gibb JW, Hanson... |
Long-term alteration in the central monoaminergic systems of the rat b... |
Eur J Pharmacol |
1992 |
| Huang X, Marona-Lewicka D... |
p-Methylthioamphetamine is a Potent New Non-Neurotoxic Serotonin-Relea... |
Eur J Pharmacol |
1992 |
| Johnson M, Elayan I, Hans... |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... |
J Pharmacol Exp Ther |
1992 |
| Krystal JH, Price LH, Ops... |
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... |
Am J Drug Alcohol Ab... |
1992 |
| Kumagai Y, Schmitz DA, Ch... |
Aromatic hydroxylation of methylenedioxybenzene (MDB) and methylenedio... |
Xenobiotica |
1992 |
| Lehmann J, DeSouza EB, Cu... |
Regional distribution to recovery of 5-HT levels after administration ... |
Ann N Y Acad Sci |
1992 |
| Paris JM, Cunningham KA |
Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... |
Brain Res Bull |
1992 |
| Ricaurte GA, McCann UD |
Neurotoxic amphetamine analogues: effects in monkeys and implications ... |
Ann N Y Acad Sci |
1992 |
| Schmidt CJ, Fadayel GM, S... |
5-HT2 receptors exert a state-dependent regulation of dopaminergic fun... |
Eur J Pharmacol |
1992 |
| Huang X, Marona-Lewicka D... |
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-relea... |
Eur J Pharmacol |
1992 |
| Glennon RA |
MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethy... |
Pharmacol Biochem Be... |
1993 |
| Jensen KF, Olin J, Haykal... |
Mapping toxicant-induced nervous system damage with a cupric silver st... |
NIDA Res Monogr |
1993 |
| Johnson M, Bush LG, Hanso... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| McCann UD, Ricaurte GA |
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... |
J Clin Psychopharmac... |
1993 |
| Ricaurte GA, Markowska AL... |
3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... |
J Pharmacol Exp Ther |
1993 |
| Rudnick G, Wall SC |
Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serot... |
Mol Pharmacol |
1993 |
| Tirzite D, Tirzitis G, Vi... |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... |
Biochem Pharmacol |
1993 |
| Gouzoulis E, von Bardeleb... |
Neuroendocrine and cardiovascular effects of MDE in healthy volunteers |
Neuropsychopharmacol... |
1993 |
| McCann UD, Ridenour A, Sh... |
Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... |
Neuropsychopharmacol... |
1994 |
| O'Callaghan JP, Miller DB |
Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... |
J Pharmacol Exp Ther |
1994 |
| Schmidt CJ, Sullivan CK, ... |
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increa... |
J Neurochem |
1994 |
| Steele TD, McCann UD, Ric... |
3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... |
Addiction |
1994 |
| Cadet JL, Ladenheim B, Hi... |
Superoxide radicals mediate the biochemical effects of methylenedioxym... |
Synapse |
1995 |
| Hegadoren KM, Martin-Iver... |
Comparative behavioural and neurochemical studies with a psychomotor s... |
Psychopharmacology (... |
1995 |
| Heller A, Won L, Heller B... |
Examination of developmental neurotoxicity by the use of tissue cultur... |
Clin Exp Pharmacol P... |
1995 |
| McNamara MG, Kelly JP, Le... |
Some behavioural and neurochemical aspects of subacute (+/-)3,4-methyl... |
Pharmacol Biochem Be... |
1995 |
| Miller DB, O'Callaghan JP |
The role of temperature, stress, and other factors in the neurotoxicit... |
Mol Neurobiol |
1995 |
| White SR, Harris GC, Imel... |
Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA... |
Brain Res |
1995 |
| Yamamoto BK, Nash JF, Gud... |
Modulation of methylenedioxymethamphetamine-induced striatal dopamine ... |
J Pharmacol Exp Ther |
1995 |
| Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
| Burns N, Olverman HJ, Kel... |
Effects of ecstasy on aldosterone secretion in the rat in vivo and in ... |
Endocr Res |
1996 |
| Dallakian P, Budzikiewicz... |
Detection and quantitation of amphetamine and methamphetamine: electro... |
J Anal Toxicol |
1996 |
| Fay J, Fogerson R, Schoen... |
Detection of methamphetamine in sweat by EIA and GC-MS |
J Anal Toxicol |
1996 |
| Jagust WJ, Eberling JL, B... |
Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the ser... |
J Nucl Med |
1996 |
| Lin LY, Fujimoto M, Diste... |
Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymetha... |
J Pharmacol Exp Ther |
1996 |
| Marona-Lewicka D, Rhee GS... |
Reinforcing effects of certain serotonin-releasing amphetamine derivat... |
Pharmacol Biochem Be... |
1996 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Saunders N |
Ecstasy and neurodegeneration. No Evidence of Neurotoxicity Exists |
BMJ |
1996 |
| Chu T, Kumagai Y, DiStefa... |
Disposition of methylenedioxymethamphetamine and three metabolites in ... |
Biochem Pharmacol |
1996 |
| Seiden LS, Sabol KE |
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possi... |
NIDA Res Monogr |
1996 |
